Studies on a larger population of patients should be performed to determine the usefulness of CA-125 and HE4 analyses and the mentioned proteins in the diagnosis of ovarian cancer and determination of resistance to chemotherapy. This evidence concerns the gene WFDC2 and ovarian cancer.